SHENOUDA MAGED purchased 25.0% of their position (200K shares) of RELMADA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $844.0K — a significant purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 9/11/2026ACC: 0001213900-26-098970
+200K
Net shares
Net buyer
$844.0K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
200K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+120.20K
Price / share
$4.20
Trade value
$504.84K
% of position
15.0%
9/9/2026
800K→920.20K
Common Stock
Direct
Shares
+79.80K
Price / share
$4.25
Trade value
$339.15K
% of position
8.7%
9/10/2026
920.20K→1M
Total
Net shares
+200K
Net value
$843.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/9/2026 | P · Purchase | +120.20K | $4.20 | $504.84K | 15.0% | 800K | 920.20K |
| Common Stock Direct | 9/10/2026 | P · Purchase | +79.80K | $4.25 | $339.15K | 8.7% | 920.20K | 1M |
| Total | +200K | $843.99K | ||||||
Derivative Transactions0
No derivative transactions reported